Back to search
FDAFDA · Food and drugs·Recall number D-993-2013

PUMICE/LIDOCAINE HCL 1.5%/1% INJ SUSP, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI

Published September 18, 2013 · Recall initiated: July 26, 2013

Summary

FDA records drug Class II recall D-993-2013, published September 18, 2013 and initiated July 26, 2013. Recalling firm: Beacon Hill Medical Pharmacy, P.C.; Status: Terminated; Reported quantity: N/A; Lot: 05202013@20. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beacon Hill Medical Pharmacy, P.C.
Distributor
USA nationwide
Lot
05202013@20
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PUMICE/LIDOCAINE HCL 1.5%/1% INJ SUSP, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI recalled?

Yes. FDA published recall D-993-2013 on September 18, 2013. Reported hazard: Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

What should I do if I have this product?

Voluntary: Firm initiated · Telephone